Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/31/2025

Administration of Octreotide

Clinical Applications and Dosing

  • The American College of Endocrinology recommends a common starting dose of 50 mcg for conditions such as dumping syndrome, administered subcutaneously before meals, with a strength of evidence based on reviews from Obesity Reviews 1, 2
  • For patients with short bowel syndrome, 50 mcg can be administered subcutaneously twice daily for antisecretory effects, as recommended by the European Society for Clinical Nutrition and Metabolism, based on a study published in Gut 3